AN AUTOCHTHONOUS MOUSE MODEL OF MyD88 p.L265P‐ AND BCL2‐DRIVEN DIFFUSE LARGE B CELL LYMPHOMA

Abstract

(PTCL); Sezary syndrome. Disclosures: Porcu, P: Consultant Advisory Role: Innate Pharma; Research Funding: Kyowa Kirin, Viracta. Kim, Y: Honoraria: kyowa Kirin, Eisai, Millennium/Takeda, Seattly Genetics, miRagen, Innate Pharma; Research Funding: Kyowa Kirin, Merck, Soligenix, FortySeven, Neumedicines, Portola Pharma, and Horizon. Zinzani, P: Honoraria: SERVIER, Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, MSD, Celltrion, Celgene, Roche; Other Remuneration: Speaker bureau: Verastem, SERVIER, Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, MSD, Celltrion, Celgene, Roche. Sicard, H: Employment Leadership Position: Innate Pharma; Stock Ownership: Innate Pharma. Azim Jr, H: Employment Leadership Position: Innate Pharma; Stock Ownership: Innate Pharma. Bagot, M: Consultant Advisory Role: Innate Pharma; Other Remuneration: Travel fees: Innate Pharma, Kyowa Kirin. Speaker Bureau: Acetlion. Patency: IPH4102.